Please assess the completion status of the following clinical trial:

Trial Title: Early Administration of Long-acting Insulin Treatment of Diabetic Ketoacidosis in Pediatric Type 1 Diabetes

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* T1DM~* Hyperglycemia \>200 mg/dl~* Bicarbonate ≤ 15 mmol/L~* pH \< 7.3~* Ketonemia~* Ketonuria~* Glucosuria~* Admission to PICU (Pediatric Intensive Care Unit)~* Ages 1-21 years~Exclusion Criteria:~* Patients who received glargine within the last 24 hours~* Patients with sepsis

- Gender: ALL
- Minimum Age: 1 Year
- Maximum Age: 21 Years
- Healthy Volunteers: f

Study Arms:
- Control Group (Type: PLACEBO_COMPARATOR): The control group will receive all traditional methods of treatment for DKA including iv insulin, correction of fluid loss, and electrolyte correction, including a placebo subcutaneous injection.
- Treatment Group (Type: EXPERIMENTAL): The study group will receive the same treatment including iv insulin, correction of fluid loss, and electrolyte correction, but will be supplemented with a subcutaneous glargine injection.

Based on this trial design, predict the completion outcome and termination type (if applicable).